Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389250 | SCV001590533 | pathogenic | Progressive myoclonic epilepsy type 3 | 2023-04-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with KCTD7-related conditions. A gross deletion of the genomic region encompassing the full coding sequence of the KCTD7 gene has been identified. Loss-of-function variants in KCTD7 are known to be pathogenic (PMID: 22693283). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. |